Film delivery system for active ingredients
AssigneeMonosol Rx, LLC
InventorGarry L. Myers
Life of this patent
Estimating the term…
Abstract
The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including testosterone esters, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided.
Claims28
A method of forming a stabilized solid form of an active agent in a solid matrix wherein said solid form is present in the form of nanoparticles, microparticles, or combinations thereof, with said method, comprising the steps of:
- a. providing a mixture of an active complex a having a melting point less than or equal to about 100° C., said active complex comprising an active agent and an excipient, and at least one water soluble polymer;
- b. adding at least a portion of said mixture to a solvent, said solvent being heated to a temperature above said melting point of said active complex whereby said active complex melts and forms a liquid dispersion of the active complex in the solvent;
- and
- c. rapidly evaporating the solvent to form a solid matrix containing a stabilized solid dispersion of said active complex in said solid matrix, wherein said active complex is present in the form of nanoparticles, microparticles, or combinations thereof.
A method of forming a stabilized solid form of a pharmaceutically active agent in a solid matrix wherein said solid form is present in the form of nanoparticles, microparticles, or combinations thereof, with said method comprising the steps of:
- a. providing a mixture of an active complex a having a melting point less than or equal to about 100° C., said active complex comprising an active agent and an excipient, and at least one water soluble polymer;
- b. adding at least a portion of said mixture to a solvent, said solvent being heated to a temperature above said melting point of said active complex whereby said active complex melts and forms a liquid dispersion of the active complex in the solvent;
- and
- c. rapidly evaporating the solvent to form a solid matrix containing a stabilized solid dispersion of said active complex in said solid matrix, wherein said active complex is present in the form of nanoparticles, microparticles, or combinations thereof;
- and
- d. gathering the resulting residue, wherein said resulting residue comprises said pharmaceutically active agent in the form of nanoparticles, microparticles, or combinations thereof.
Dependencies are inferred from the claim text.